Published in Ophthalmology on May 01, 2003
Methotrexate and Mycophenolate Mofetil for UVEITIS (FAST) | NCT01829295
Myfortic for the Treatment of Non-infectious Intermediate Uveitis (MYCUV-IIT02) | NCT01092533
Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int (2011) 1.64
Emerging drugs for uveitis. Expert Opin Emerg Drugs (2011) 1.08
Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol (2006) 1.02
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol (2005) 1.00
Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol (2007) 0.97
A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology (2014) 0.88
Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye (Lond) (2011) 0.88
Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.82
Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis. Recent Pat Biomed Eng (2012) 0.82
Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol (2014) 0.81
Pharmacokinetics, electrophysiological, and morphological effects of the intravitreal injection of mycophenolic acid in rabbits. J Ocul Pharmacol Ther (2014) 0.80
[Uveitis in juvenile idiopathic arthritis]. Z Rheumatol (2010) 0.77
Effects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitro. Mol Vis (2010) 0.77
Diagnostic techniques for inflammatory eye disease: past, present and future: a review. BMC Ophthalmol (2013) 0.76
Systemic treatment of vitreous inflammation. Mediators Inflamm (2012) 0.75
Combination immunotherapy in the treatment of chronic bilateral panuveitis and uveitic glaucoma during acute dengue fever infection in the Caribbean. Int Med Case Rep J (2015) 0.75
Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World J Gastroenterol (2017) 0.75
Mycophenolate mofetil therapy in uveitis: analysis of eight cases in a tertiary ophthalmic care centre in India. Int Ophthalmol (2007) 0.75
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol (2011) 3.63
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol (2006) 2.13
The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol (2002) 2.10
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol (2005) 2.01
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87
Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology (2011) 1.85
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology (2005) 1.69
Relapsing polychondritis: a clinical review. Semin Arthritis Rheum (2002) 1.68
Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology (2007) 1.66
Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm (2010) 1.62
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Ocular pemphigus. J Am Acad Dermatol (2005) 1.56
Azathioprine for ocular inflammatory diseases. Am J Ophthalmol (2009) 1.44
Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol (2004) 1.33
Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology (2005) 1.33
Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin (2006) 1.25
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23
Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res (2004) 1.20
Multifocal choroiditis and panuveitis: immunomodulatory therapy. Ophthalmology (2002) 1.20
Primary intraocular lymphoma: A review. Semin Ophthalmol (2006) 1.19
Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina (2009) 1.19
360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol (2004) 1.18
Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol (2003) 1.16
High-dose methotrexate for intraocular lymphoma. Clin Cancer Res (2003) 1.15
Cyclophosphamide for ocular inflammatory diseases. Ophthalmology (2009) 1.14
Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 1.14
Glaucoma and uveitis. Surv Ophthalmol (2012) 1.13
Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol (2007) 1.12
Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina (2007) 1.11
Anterior segment optical coherence tomography. Semin Ophthalmol (2010) 1.09
Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm (2008) 1.09
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08
Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology (2005) 1.08
Scleritis therapy. Ophthalmology (2011) 1.07
Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology (2002) 1.07
Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology (2006) 1.07
Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm (2009) 1.06
Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol (2011) 1.05
Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surg Lasers Imaging (2009) 1.05
Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol (2003) 1.04
The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol (2008) 1.04
Risk of hypotony in noninfectious uveitis. Ophthalmology (2012) 1.03
The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. J Ophthalmol (2010) 1.02
Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol (2013) 1.02
Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm (2004) 1.02
Subconjunctival bevacizumab for corneal neovascularization. Cornea (2008) 1.02
Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol (2007) 1.01
Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology (2008) 1.01
The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci (2003) 1.01
Ocular manifestations and concepts of systemic vasculitides. Surv Ophthalmol (2004) 1.01
Infliximab for the treatment of refractory scleritis. Br J Ophthalmol (2009) 1.01
Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology (2002) 1.00
Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol (2006) 1.00
Hypopyon in patients with uveitis. Ophthalmology (2009) 0.99
Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm (2004) 0.99
Scleral necrosis in a patient with congenital erythropoietic porphyria. Cornea (2011) 0.98
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology (2012) 0.97
Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol (2007) 0.97
Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil. Am J Ophthalmol (2005) 0.97
Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Ophthalmology (2003) 0.96
Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm (2011) 0.96
Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol (2011) 0.96
Chronic postoperative endophthalmitis due to pseudomonas oryzihabitans. Am J Ophthalmol (2002) 0.96
Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol (2009) 0.96
Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology (2003) 0.96
Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor (2009) 0.95
Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg (2005) 0.94
Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis. Ophthalmology (2005) 0.93
A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther (2013) 0.93
Multifocal nodular episcleritis and scleritis with undiagnosed Hodgkin's lymphoma. Ophthalmology (2003) 0.93
Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol (2002) 0.93
Solitary myofibroma of the sclera. Cornea (2007) 0.92
Mucous membrane pemphigoid: an update. Curr Opin Ophthalmol (2005) 0.92
Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases. Ophthalmology (2012) 0.92
Ocular and extracutaneous involvement in pyoderma gangrenosum. Ophthalmology (2002) 0.92
Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study. Invest Ophthalmol Vis Sci (2014) 0.92
Mooren ulcer: an immunopathologic study. Cornea (2006) 0.91
Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 0.91
Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm (2007) 0.91
Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm (2009) 0.91
Cytomegalovirus retinitis in immunocompetent patients: case reports and literature review. Ocul Immunol Inflamm (2013) 0.91
Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol (2002) 0.91
Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer (2005) 0.90
Response of pediatric uveitis to tumor necrosis factor-α inhibitors. J Rheumatol (2013) 0.90
Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol (2007) 0.89
The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology (2002) 0.89
Adamantiades-Behcet disease: diagnosis and current concepts in management of ocular manifestations. Compr Ophthalmol Update (2007) 0.89
Cataract surgery in patients with history of uveitis. Saudi J Ophthalmol (2012) 0.88
Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology (2002) 0.88
Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm (2006) 0.88
Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocul Immunol Inflamm (2012) 0.88